The story of Viagra presents a complex case for stakeholders in the medicinal sector. While initially a tremendous success, generating billions, the exclusivity expiration and the subsequent arrival of off-brand https://online-pharmacy637134.myparisblog.com/42313379/the-little-copyright-and-the-pharmaceutical-industry-a-hazardous-bet